 | • レポートコード：MRC-IPR02976 • 出版社/出版日：GlobalInfoResearch / 2025年9月 • レポート形態：英語、PDF、約100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：製薬 |
| Single User | ￥528,960 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥793,440 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,057,920 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本レポートは、VHH抗体医薬品の世界市場を対象とした詳細な分析を提供し、2024年時点の市場規模を基準に2031年までの成長を予測している。定量分析と定性分析を組み合わせ、メーカー別、地域別、製品タイプ別、用途別の市場動向を体系的に整理している。市場は医薬品研究の進展や新規抗体技術の需要増加を背景に変化しており、特に特異性の高さや小型で安定性に優れたVHH抗体の利点が評価されている。 本レポートの主要目的は、世界および主要国市場の潜在市場規模の算定、成長可能性の評価、製品・用途別の将来予測、競争状況の分析である。企業概要、販売数量、売上、価格、粗利益、製品ポートフォリオ、地域展開、主要な開発状況に基づき、Novamab、Sanofi（Ablynx）、Alphamab Oncologyなど主要企業が取り上げられる。市場の成長要因、抑制要因、新製品や承認動向、ビジネス機会についても示され、競争環境および市場ドライバーの理解に資する。 市場はタイプ別に二重特異性抗体と単一特異性抗体に分類され、用途別には病院、クリニック、その他に区分されている。地域別分析では北米、欧州、アジア太平洋、南米、中東・アフリカを対象とし、2020～2031年の期間で消費額、販売数量、平均販売価格を予測する。レポート構成は、製品概要、メーカー競争分析、地域別および国別市場動向、セグメント別成長動向、産業チェーン、ポーターの五力分析、販売チャネル、顧客分析など全15章で構成され、VHH抗体医薬品市場の戦略立案や投資判断に有用な包括的情報を提供している。 |
According to our (Global Info Research) latest study, the global VHH Antibody Drugs market size was valued at US$ xx million in 2024 and is forecast to a readjusted size of USD xx million by 2031 with a CAGR of xx% during review period.
This report is a detailed and comprehensive analysis for global VHH Antibody Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global VHH Antibody Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global VHH Antibody Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global VHH Antibody Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global VHH Antibody Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for VHH Antibody Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global VHH Antibody Drugs market based on the following parameters – company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novamab, Sanofi Company(Ablynx), Alphamab Oncology, , etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
VHH Antibody Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bispecific
Monospecific
Market segment by Application
Hospital
Clinic
Other
Major players covered
Novamab
Sanofi Company(Ablynx)
Alphamab Oncology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe VHH Antibody Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of VHH Antibody Drugs, with price, sales quantity, revenue, and global market share of VHH Antibody Drugs from 2020 to 2025.
Chapter 3, the VHH Antibody Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the VHH Antibody Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and VHH Antibody Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of VHH Antibody Drugs.
Chapter 14 and 15, to describe VHH Antibody Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global VHH Antibody Drugs Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Bispecific
1.3.3 Monospecific
1.4 Market Analysis by Application
1.4.1 Overview: Global VHH Antibody Drugs Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global VHH Antibody Drugs Market Size & Forecast
1.5.1 Global VHH Antibody Drugs Consumption Value (2020 & 2024 & 2031)
1.5.2 Global VHH Antibody Drugs Sales Quantity (2020-2031)
1.5.3 Global VHH Antibody Drugs Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Novamab
2.1.1 Novamab Details
2.1.2 Novamab Major Business
2.1.3 Novamab VHH Antibody Drugs Product and Services
2.1.4 Novamab VHH Antibody Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Novamab Recent Developments/Updates
2.2 Sanofi Company(Ablynx)
2.2.1 Sanofi Company(Ablynx) Details
2.2.2 Sanofi Company(Ablynx) Major Business
2.2.3 Sanofi Company(Ablynx) VHH Antibody Drugs Product and Services
2.2.4 Sanofi Company(Ablynx) VHH Antibody Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Sanofi Company(Ablynx) Recent Developments/Updates
2.3 Alphamab Oncology
2.3.1 Alphamab Oncology Details
2.3.2 Alphamab Oncology Major Business
2.3.3 Alphamab Oncology VHH Antibody Drugs Product and Services
2.3.4 Alphamab Oncology VHH Antibody Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Alphamab Oncology Recent Developments/Updates
3 Competitive Environment: VHH Antibody Drugs by Manufacturer
3.1 Global VHH Antibody Drugs Sales Quantity by Manufacturer (2020-2025)
3.2 Global VHH Antibody Drugs Revenue by Manufacturer (2020-2025)
3.3 Global VHH Antibody Drugs Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of VHH Antibody Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 VHH Antibody Drugs Manufacturer Market Share in 2024
3.4.3 Top 6 VHH Antibody Drugs Manufacturer Market Share in 2024
3.5 VHH Antibody Drugs Market: Overall Company Footprint Analysis
3.5.1 VHH Antibody Drugs Market: Region Footprint
3.5.2 VHH Antibody Drugs Market: Company Product Type Footprint
3.5.3 VHH Antibody Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global VHH Antibody Drugs Market Size by Region
4.1.1 Global VHH Antibody Drugs Sales Quantity by Region (2020-2031)
4.1.2 Global VHH Antibody Drugs Consumption Value by Region (2020-2031)
4.1.3 Global VHH Antibody Drugs Average Price by Region (2020-2031)
4.2 North America VHH Antibody Drugs Consumption Value (2020-2031)
4.3 Europe VHH Antibody Drugs Consumption Value (2020-2031)
4.4 Asia-Pacific VHH Antibody Drugs Consumption Value (2020-2031)
4.5 South America VHH Antibody Drugs Consumption Value (2020-2031)
4.6 Middle East & Africa VHH Antibody Drugs Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global VHH Antibody Drugs Sales Quantity by Type (2020-2031)
5.2 Global VHH Antibody Drugs Consumption Value by Type (2020-2031)
5.3 Global VHH Antibody Drugs Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global VHH Antibody Drugs Sales Quantity by Application (2020-2031)
6.2 Global VHH Antibody Drugs Consumption Value by Application (2020-2031)
6.3 Global VHH Antibody Drugs Average Price by Application (2020-2031)
7 North America
7.1 North America VHH Antibody Drugs Sales Quantity by Type (2020-2031)
7.2 North America VHH Antibody Drugs Sales Quantity by Application (2020-2031)
7.3 North America VHH Antibody Drugs Market Size by Country
7.3.1 North America VHH Antibody Drugs Sales Quantity by Country (2020-2031)
7.3.2 North America VHH Antibody Drugs Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe VHH Antibody Drugs Sales Quantity by Type (2020-2031)
8.2 Europe VHH Antibody Drugs Sales Quantity by Application (2020-2031)
8.3 Europe VHH Antibody Drugs Market Size by Country
8.3.1 Europe VHH Antibody Drugs Sales Quantity by Country (2020-2031)
8.3.2 Europe VHH Antibody Drugs Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific VHH Antibody Drugs Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific VHH Antibody Drugs Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific VHH Antibody Drugs Market Size by Region
9.3.1 Asia-Pacific VHH Antibody Drugs Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific VHH Antibody Drugs Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America VHH Antibody Drugs Sales Quantity by Type (2020-2031)
10.2 South America VHH Antibody Drugs Sales Quantity by Application (2020-2031)
10.3 South America VHH Antibody Drugs Market Size by Country
10.3.1 South America VHH Antibody Drugs Sales Quantity by Country (2020-2031)
10.3.2 South America VHH Antibody Drugs Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa VHH Antibody Drugs Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa VHH Antibody Drugs Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa VHH Antibody Drugs Market Size by Country
11.3.1 Middle East & Africa VHH Antibody Drugs Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa VHH Antibody Drugs Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 VHH Antibody Drugs Market Drivers
12.2 VHH Antibody Drugs Market Restraints
12.3 VHH Antibody Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of VHH Antibody Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of VHH Antibody Drugs
13.3 VHH Antibody Drugs Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 VHH Antibody Drugs Typical Distributors
14.3 VHH Antibody Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global VHH Antibody Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global VHH Antibody Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Novamab Basic Information, Manufacturing Base and Competitors
Table 4. Novamab Major Business
Table 5. Novamab VHH Antibody Drugs Product and Services
Table 6. Novamab VHH Antibody Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Novamab Recent Developments/Updates
Table 8. Sanofi Company(Ablynx) Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Company(Ablynx) Major Business
Table 10. Sanofi Company(Ablynx) VHH Antibody Drugs Product and Services
Table 11. Sanofi Company(Ablynx) VHH Antibody Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Sanofi Company(Ablynx) Recent Developments/Updates
Table 13. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 14. Alphamab Oncology Major Business
Table 15. Alphamab Oncology VHH Antibody Drugs Product and Services
Table 16. Alphamab Oncology VHH Antibody Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Alphamab Oncology Recent Developments/Updates
Table 18. Global VHH Antibody Drugs Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 19. Global VHH Antibody Drugs Revenue by Manufacturer (2020-2025) & (USD Million)
Table 20. Global VHH Antibody Drugs Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 21. Market Position of Manufacturers in VHH Antibody Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 22. Head Office and VHH Antibody Drugs Production Site of Key Manufacturer
Table 23. VHH Antibody Drugs Market: Company Product Type Footprint
Table 24. VHH Antibody Drugs Market: Company Product Application Footprint
Table 25. VHH Antibody Drugs New Market Entrants and Barriers to Market Entry
Table 26. VHH Antibody Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global VHH Antibody Drugs Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 28. Global VHH Antibody Drugs Sales Quantity by Region (2020-2025) & (K Units)
Table 29. Global VHH Antibody Drugs Sales Quantity by Region (2026-2031) & (K Units)
Table 30. Global VHH Antibody Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 31. Global VHH Antibody Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 32. Global VHH Antibody Drugs Average Price by Region (2020-2025) & (US$/Unit)
Table 33. Global VHH Antibody Drugs Average Price by Region (2026-2031) & (US$/Unit)
Table 34. Global VHH Antibody Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 35. Global VHH Antibody Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 36. Global VHH Antibody Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 37. Global VHH Antibody Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 38. Global VHH Antibody Drugs Average Price by Type (2020-2025) & (US$/Unit)
Table 39. Global VHH Antibody Drugs Average Price by Type (2026-2031) & (US$/Unit)
Table 40. Global VHH Antibody Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 41. Global VHH Antibody Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 42. Global VHH Antibody Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 43. Global VHH Antibody Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 44. Global VHH Antibody Drugs Average Price by Application (2020-2025) & (US$/Unit)
Table 45. Global VHH Antibody Drugs Average Price by Application (2026-2031) & (US$/Unit)
Table 46. North America VHH Antibody Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 47. North America VHH Antibody Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 48. North America VHH Antibody Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 49. North America VHH Antibody Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 50. North America VHH Antibody Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 51. North America VHH Antibody Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 52. North America VHH Antibody Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 53. North America VHH Antibody Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 54. Europe VHH Antibody Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 55. Europe VHH Antibody Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 56. Europe VHH Antibody Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 57. Europe VHH Antibody Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 58. Europe VHH Antibody Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 59. Europe VHH Antibody Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 60. Europe VHH Antibody Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 61. Europe VHH Antibody Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 62. Asia-Pacific VHH Antibody Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 63. Asia-Pacific VHH Antibody Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 64. Asia-Pacific VHH Antibody Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 65. Asia-Pacific VHH Antibody Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 66. Asia-Pacific VHH Antibody Drugs Sales Quantity by Region (2020-2025) & (K Units)
Table 67. Asia-Pacific VHH Antibody Drugs Sales Quantity by Region (2026-2031) & (K Units)
Table 68. Asia-Pacific VHH Antibody Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 69. Asia-Pacific VHH Antibody Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 70. South America VHH Antibody Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 71. South America VHH Antibody Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 72. South America VHH Antibody Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 73. South America VHH Antibody Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 74. South America VHH Antibody Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 75. South America VHH Antibody Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 76. South America VHH Antibody Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 77. South America VHH Antibody Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 78. Middle East & Africa VHH Antibody Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 79. Middle East & Africa VHH Antibody Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 80. Middle East & Africa VHH Antibody Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 81. Middle East & Africa VHH Antibody Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 82. Middle East & Africa VHH Antibody Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 83. Middle East & Africa VHH Antibody Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 84. Middle East & Africa VHH Antibody Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 85. Middle East & Africa VHH Antibody Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 86. VHH Antibody Drugs Raw Material
Table 87. Key Manufacturers of VHH Antibody Drugs Raw Materials
Table 88. VHH Antibody Drugs Typical Distributors
Table 89. VHH Antibody Drugs Typical Customers
インピーダンスベースTEER測定システム市場2025年 According to our (Global Info Research) latest study, the global Impedance-based TEER Measurement System market size was valued at US$ 83 million in 2024 and is forecast to a readjusted size of USD 125 million by 2031 with a CAGR of 6.1% during review period. Impedance-based TEER (Trans Epithelial/E…- エアロデリバティブガスタービンの世界市場2025 According to our (Global Info Research) latest study, the global Aeroderivative Gas Turbine market size was valued at US$ 1385 million in 2024 and is forecast to a readjusted size of USD 1542 million by 2031 with a CAGR of 1.6% during review period. The aeroderivative gas turbine is a lighter weight…
世界のポリエチレン・ワックス市場2025年 According to our (Global Info Research) latest study, the global Polyethylene Wax market size was valued at US$ 1301 million in 2024 and is forecast to a readjusted size of USD 1594 million by 2031 with a CAGR of 2.9% during review period. In this report, we will assess the current U.S. tariff frame…- 世界の光学的透明接着剤(OCA)市場2025-2031 The global Optically Clear Adhesive market size was US$ 1360 million in 2024 and is forecast to a readjusted size of US$ 1892 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031. The North America Optically Clear Adhesive market size was US$ million in 2024, while Europe was US$…
- 世界の自動車金属部品市場2025 The global Automotive Metal Parts market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Automotive industry metal parts are components or parts that made of metal materials of automotives. Automotive is a…